Teva launches generic version of Imitrex injection

NEW YORK -- Teva Pharmaceuticals has added Sumatriptan Injection, USP (autoinjector) to its line of generic products.

The product is AB rated and bioequivalent to Imitrex (sumatriptan succinate) Injection, and is available in strengths of 4 mg/0.5 mL and 6 mg/0.5 mL.

Both strengths are offered in cartons containing two autoinjectors, each with a prefilled 0.5 mL single-dose syringe.